These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 26541791)
1. New therapeutic strategies regarding endovascular treatment of glioblastoma, the role of the blood-brain barrier and new ways to bypass it. Peschillo S; Caporlingua A; Diana F; Caporlingua F; Delfini R J Neurointerv Surg; 2016 Oct; 8(10):1078-82. PubMed ID: 26541791 [TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma. Dréan A; Goldwirt L; Verreault M; Canney M; Schmitt C; Guehennec J; Delattre JY; Carpentier A; Idbaih A Expert Rev Neurother; 2016 Nov; 16(11):1285-1300. PubMed ID: 27310463 [TBL] [Abstract][Full Text] [Related]
3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797 [TBL] [Abstract][Full Text] [Related]
4. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment. Wang D; Wang C; Wang L; Chen Y Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355 [TBL] [Abstract][Full Text] [Related]
5. Drug delivery approaches for the treatment of glioblastoma multiforme. Fakhoury M Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399 [TBL] [Abstract][Full Text] [Related]
6. Harnessing nanomedicine for therapeutic intervention in glioblastoma. Gutkin A; Cohen ZR; Peer D Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticles: Novel vehicles in treatment of Glioblastoma. Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272 [TBL] [Abstract][Full Text] [Related]
8. Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again? Joshi S; Ellis JA; Ornstein E; Bruce JN J Neurooncol; 2015 Sep; 124(3):333-43. PubMed ID: 26108656 [TBL] [Abstract][Full Text] [Related]
9. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach. Agarwal S; Muniyandi P; Maekawa T; Kumar DS Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647 [TBL] [Abstract][Full Text] [Related]
10. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous. Drapeau A; Fortin D Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730 [TBL] [Abstract][Full Text] [Related]
12. Surgical Adjuncts for Glioblastoma. Hartnett S; Kroll D; Vogelbaum MA Neurosurg Clin N Am; 2021 Jan; 32(1):83-91. PubMed ID: 33223029 [TBL] [Abstract][Full Text] [Related]
13. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme. Jena L; McErlean E; McCarthy H Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942 [TBL] [Abstract][Full Text] [Related]
14. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment. Ganipineni LP; Danhier F; Préat V J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958 [TBL] [Abstract][Full Text] [Related]
15. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review. Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997 [TBL] [Abstract][Full Text] [Related]
17. Endovascular therapies for malignant gliomas: Challenges and the future. Su YS; Ali R; Feroze AH; Li G; Lawton MT; Choudhri O J Clin Neurosci; 2016 Apr; 26():26-32. PubMed ID: 26857294 [TBL] [Abstract][Full Text] [Related]
18. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art. Karim R; Palazzo C; Evrard B; Piel G J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752 [TBL] [Abstract][Full Text] [Related]
19. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature. Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514 [TBL] [Abstract][Full Text] [Related]
20. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]